# A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

> **NCT00938158** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 75 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **BIOLOGICAL:** albiglutide

## Key facts

- **NCT ID:** NCT00938158
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-05
- **Primary completion:** 2011-04-12
- **Final completion:** 2011-04-12
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938158, "A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00938158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*